Granting of partially refundable aid for the development of a new quarterly formulation of Risperidone


No votes yet
 
Related
  Madrid, 12 April, 2023 The Universidad Pontificia Comillas, in collaboration with Laboratorios Farmacéuticos ROVI, has created...
3 min
12/04/2023
Madrid, 27 March 2023 Laboratorios Farmacéuticos ROVI and ReTree are collaborating to plant ROVI’s Forest in the Madrid Sierra. It is an...
3 min
27/03/2023
Madrid, 21 March 2023 Laboratorios Farmacéuticos ROVI announces its incorporation as a member of the General Assembly of the Spanish...
3 min
21/03/2023